Conjoint Tendon Resection During Reverse Total Shoulder Arthroplasty
Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Feb 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new surgical technique to improve shoulder function after a procedure called reverse total shoulder arthroplasty (RTSA). RTSA is often performed on patients with severe rotator cuff tears, helping to restore movement in the shoulder. However, many patients still struggle with moving their hands behind their bodies, which is known as internal rotation. This trial will compare the standard RTSA method to a modified approach that includes removing a specific part of the tendon to see if it leads to better results in this area.
If you are a patient who is planning to have a primary RTSA and is looking for ways to enhance your shoulder movement, you might be eligible to participate in this study. The trial is open to all patients over a certain age, but it does not include those who are having revision surgeries or surgeries related to specific types of fractures. Participants can expect to undergo the standard RTSA procedure, with the possibility of receiving the new technique, and will be monitored afterward to see how well they can move their arms. This could be an important opportunity to help improve shoulder function and overall satisfaction with the surgery.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • - All patients undergoing primary reverse total shoulder arthroplasty (RTSA)
- • Exclusion criteria
- • Revision RTSA
- • RTSA for acute proximal humerus fracture or fracture sequela
About University Of Missouri Columbia
The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials